drugset / Trial / NCT00590928

Gastric pH in Critically Ill Patients

NCT00590928

Phase 4 Completed 75 enrolled Medical University of Vienna
RandomizedParallel-groupDouble-blindTreatment

Summary

H2-receptor antagonists are the gold standard for stress ulcer prophylaxis in critically ill patients. Various studies demonstrated superiority of proton pump inhibitors over H2-receptor antagonists in increasing gastric pH and in healing gastric acid-dependent diseases. It is unknown, whether proton pump inhibitors are more effective in increasing gastric pH than H2-receptor antagonists in critically ill patients requiring stress ulcer prophylaxis.

Timeline

Start
2004-07
Primary completion
2006-06
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Esomeprazole Small molecule 40 mg Intravenous
Comparator Ranitidine Unknown 50 mg

Indications

No indication recorded.